About Andrew Levin
Andrew Levin is a director at Imbria Pharmaceuticals.
Andrew Levin first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Levin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Levin works with at each company, as listed on that company's latest Form D.
Imbria Pharmaceuticals, Inc. · Form D/A, Dec 16, 2025
PC
Pavan Cheruvu
Director
CD
Charles Dunn
Director
AS
Alvin Shih
Executive officer and director
LR
Luse Rebecca
Director
KH
Ken Horne
Director
KJ
Komal Joshi
Secretary
Zina Affas Besse
Director